Global Histology and Cytology IVD Market Report 2021-2022 & 2026 with Competitive Analysis of Agilent, Danaher, Hologic, Illumina, & Roche
30 Jun 2022
DUBLIN, June 30, 2022 /PRNewswire/ -- The "Histology and Cytology IVD Market Update" report has been added to
ResearchAndMarkets.com's offering.
This report, Histology and Cytology IVD Market Update, provides competitive analysis of the histology/cytology market from 2021 to 2026.
Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination.
Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the knowledge and understanding of the shape-function relationships within tissues and organs and their relationship to disease.
The industry has forged ahead with new technologies that offer increased accuracy and automated workflow. In the coming years, digital imaging, quantitative microscopy, precision microscopy, artificial intelligence and virtual histology will take the histology/cytology industry to the next level.
As discussed in the report, the histology market is a growing market with much potential. This report only looks at traditional histology.
Report Scope
All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests. The base year for data was 2021. Data are provided for 2021 and 2026 with compound annual growth rates (CAGRs) for 2021 and 2026.
Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, Europe, Asia-Pacific and the Rest of World for 2021.
The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.
The histology report is segmented into five areas:
Traditional non-PAP Stains
PAP
In situ Hybridization
Immunohistochemistry
HPV
The histology report also examines and profiles five key market participants:
Hologic
Key Topics Covered:
Chapter 1: Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Global Histology IVD Market, 2021-2026 ($millions)
Competitive Outlook
Chapter 2: Market Analysis
Overview Of Histology/Cytology
Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL)
Histology/Cytology Diagnostic Market Distribution by Broad Test Category, 2021
Market Segment by Test Type
Traditional Tissue Stains
Selected Vendors of Traditional Histology Stains
Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019 (last updated 2020-02-12)
Immunohistochemistry and In-Situ Hybridization
Selected in Situ Hybridization-based Tests
Selected IHC Test Innovations
HPV
HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2021
Global HPV Molecular (DNA/RNA) Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
Selected HPV Test Innovations
Market by Region
Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
Competitive Analysis
Revenues of the Major Histology Companies, 2017-2021 ($ millions, estimated)
2022 Pathology Launches by Roche
The Commercial Outlook for Histology
Chapter 3: Major Market Participants
Hologic
For more information about this report visit https://www.researchandmarkets.com/r/6xd9j3
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.